title: Feasibility and safety of robotic surgery for gynecologic cancers.
abstract: BACKGROUND
  To determine surgical outcomes, perioperative complications, and patient outcomes in gynecologic cancer patients undergoing robotic surgery.
  
  
  METHODS
  Surgical outcomes, including docking time, total operative time, console time, estimated blood loss (EBL), conversion rate and perioperative complications were retrospectively reviewed in 30 gynecologic cancer patients undergoing robotic surgery. Patient outcomes included recovery time and patient satisfaction, as scored by a visual analogue scale (VAS) from 0-10.
  
  
  RESULTS
  The operations included 24 hysterectomies with pelvic lymphadenectomy (PLD) and/or para-aortic lymphadenectomy, four radical hysterectomies with PLD, and two radical trachelectomies with PLD. Mean docking time was 12.8 ± 9.7 min, total operative time was 345.5 ± 85.0 min, and console time was 281.9 ± 78.6 min. These times were decreased in the second half of the cases. There was no conversion rate. Three intraoperative complications, including one external iliac artery injury, one bladder injury, and one massive bleeding requiring blood transfusion were reported. Postoperative complications occurred in eight patients, most were minor. Only one patient had port herniation that required reoperation. Mean hospital stay was 3.5 ± 1.7 days, and recovery time was 14.2 ± 8.1 days. Two-thirds of patients felt very satisfied and one-third felt satisfied; the mean satisfaction score was 9.4 +0.9. Two patients with stage III endometrial cancer developed isolated port site metastasis at five and 13 months postoperatively.
  
  
  CONCLUSIONS
  Robotic surgery for gynecologic cancer appears to be feasible, with acceptable perioperative complication rate, fast recovery time and high patient satisfaction.
authors.affiliation: Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand E-mail : T_manchana@hotmail.com.
authors.forename: Tarinee
authors.initials: T
authors.lastname: Manchana
authors.forename: Nakarin
authors.initials: N
authors.lastname: Sirisabya
authors.forename: Apichai
authors.initials: A
authors.lastname: Vasuratna
authors.forename: Wichai
authors.initials: W
authors.lastname: Termrungruanglert
authors.forename: Damrong
authors.initials: D
authors.lastname: Tresukosol
authors.forename: Wirach
authors.initials: W
authors.lastname: Wisawasukmongchol
mesh_terms: D000328:Adult; D005260:Female; D005833:Genital Neoplasms, Female / Q000601:surgery*; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects; D007431:Intraoperative Complications / Q000209:etiology; D007902:Length of Stay; D008197:Lymph Node Excision / Q000009:adverse effects; D008875:Middle Aged; D059035:Perioperative Period; D011183:Postoperative Complications / Q000209:etiology; D012189:Retrospective Studies; D012371:Robotics / Q000379:methods; D013514:Surgical Procedures, Operative / Q000009:adverse effects*